BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25875860)

  • 1. A case of β-catenin-positive hepatocellular adenoma with MR imaging sign of diffuse intratumoral fat deposition.
    Ishii M; Kazaoka J; Fukushima J; Gunji M; Aoyama T; Fukusato T; Sano K; Kondo F; Takeshita T; Furui S; Akahane M
    Abdom Imaging; 2015 Aug; 40(6):1487-91. PubMed ID: 25875860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
    Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
    AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification.
    Laumonier H; Bioulac-Sage P; Laurent C; Zucman-Rossi J; Balabaud C; Trillaud H
    Hepatology; 2008 Sep; 48(3):808-18. PubMed ID: 18688875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature.
    Hechtman JF; Raoufi M; Fiel MI; Taouli B; Facciuto M; Schiano TD; Blouin AG; Thung SN
    Am J Surg Pathol; 2011 Jun; 35(6):927-32. PubMed ID: 21572265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
    van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
    J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
    [TBL] [Abstract][Full Text] [Related]  

  • 6.  Pigmented hepatocellular adenoma with β-catenin activation: case report and literature review.
    Coelho R; Gonçalves R; Carneiro F; Fernandes M; Lopes J; Guimarães S; Macedo G
    Ann Hepatol; 2016; 15(4):598-603. PubMed ID: 27236161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.
    Thomeer MG; E Bröker ME; de Lussanet Q; Biermann K; Dwarkasing RS; de Man R; Ijzermans JN; de Vries M
    Diagn Interv Radiol; 2014; 20(3):193-9. PubMed ID: 24509184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification.
    van Aalten SM; Thomeer MG; Terkivatan T; Dwarkasing RS; Verheij J; de Man RA; Ijzermans JN
    Radiology; 2011 Oct; 261(1):172-81. PubMed ID: 21875850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
    Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
    Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Hepatocellular Adenoma: Recent Advances.
    Agrawal S; Agarwal S; Arnason T; Saini S; Belghiti J
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1221-30. PubMed ID: 24909909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular adenoma: An unsolved diagnostic enigma.
    Renzulli M; Clemente A; Tovoli F; Cappabianca S; Bolondi L; Golfieri R
    World J Gastroenterol; 2019 May; 25(20):2442-2449. PubMed ID: 31171888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
    Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
    Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
    Agarwal S; Fuentes-Orrego JM; Arnason T; Misdraji J; Jhaveri KS; Harisinghani M; Hahn PF
    AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
    Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
    Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.
    Bioulac-Sage P; Cubel G; Taouji S; Scoazec JY; Leteurtre E; Paradis V; Sturm N; Nhieu JT; Wendum D; Bancel B; Ramos J; Paraf F; Saint Paul MC; Michalak S; Fabre M; Guettier C; Le Bail B; Zucman-Rossi J; Balabaud C
    Am J Surg Pathol; 2012 Nov; 36(11):1691-9. PubMed ID: 23060349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.
    Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X
    Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
    Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
    AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
    [No Abstract]   [Full Text] [Related]  

  • 19. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
    Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J
    Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype classification of hepatocellular adenoma.
    Bioulac-Sage P; Balabaud C; Zucman-Rossi J
    Dig Surg; 2010; 27(1):39-45. PubMed ID: 20357450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.